Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2008 1
2009 2
2010 4
2011 4
2012 5
2013 5
2014 4
2015 3
2016 2
2017 4
2018 3
2019 3
2020 3
2021 6
2022 3
2023 4
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
The dopamine theory of addiction: 40 years of highs and lows.
Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR. Nutt DJ, et al. Among authors: stokes pr. Nat Rev Neurosci. 2015 May;16(5):305-12. doi: 10.1038/nrn3939. Epub 2015 Apr 15. Nat Rev Neurosci. 2015. PMID: 25873042 Free article. Review.
Academic psychiatry is everyone's business.
Critchley HD, Tracy DK, Malhi GS, Alexander L, Baldwin DS, Cavanagh J, Chamberlain SR, Cipriani A, Farooq S, Hassiotis A, Howes O, Jauhar S, Lawrie SM, Lagunes-Cordoba E, Lingford-Hughes A, MacCabe JH, Memon I, Mulholland C, Sami M, Sayal K, Shankar R, Sinclair L, Sparasci O, Staufenberg EFA, Stirland LE, Stokes PRA, Jones CW, Woodruff PWR, Young AH. Critchley HD, et al. Among authors: stokes pra. Br J Psychiatry. 2024 Dec;225(6):521-525. doi: 10.1192/bjp.2024.152. Br J Psychiatry. 2024. PMID: 39411847
Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysis.
Giménez-Palomo A, Chamdal AK, Gottlieb N, Lotfaliany M, Jokinen T, Bastawy EM, Adlington K, Benachar N, Dodd S, Pacchiarotti I, Vieta E, Berk M, Stokes PRA. Giménez-Palomo A, et al. Among authors: stokes pra. Acta Psychiatr Scand. 2024 Dec;150(6):500-515. doi: 10.1111/acps.13728. Epub 2024 Jul 12. Acta Psychiatr Scand. 2024. PMID: 39001570 Review.
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
Miskowiak KW, Obel ZK, Guglielmo R, Bonnin CDM, Bowie CR, Balanzá-Martínez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Kessing LV, Lafer B, Lewandowski KE, López-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Hasler G. Miskowiak KW, et al. Among authors: stokes pra. Bipolar Disord. 2024 May;26(3):216-239. doi: 10.1111/bdi.13414. Epub 2024 Mar 3. Bipolar Disord. 2024. PMID: 38433530 Review.
The blood-brain barrier in bipolar disorders: A systematic review.
Wakonigg Alonso C, McElhatton F, O'Mahony B, Campbell M, Pollak TA, Stokes PRA. Wakonigg Alonso C, et al. Among authors: stokes pra. J Affect Disord. 2024 Sep 15;361:434-444. doi: 10.1016/j.jad.2024.06.032. Epub 2024 Jun 17. J Affect Disord. 2024. PMID: 38897301
48 results